Saturday, 5 May 2012
Aza- and diaza-phthalazine compounds as p38 map kinase modulators and methods of use thereof
Abstract: The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula (I) wherein A1, A2, A3, A4, L, R1, R2, R3, R5 and m are as defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of p38 map kinase mediated diseases
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment